I-Mab ADR (NASDAQ:IMAB)’s traded shares stood at 0.36 million during the last session, with the company’s beta value hitting 1.40. At the close of trading, the stock’s price was $2.15, to imply a decrease of -6.11% or -$0.14 in intraday trading. The IMAB share’s 52-week high remains $3.08, putting it -43.26% down since that peak but still an impressive 72.09% since price per share fell to its 52-week low of $0.60. The company has a valuation of $169.72M, with an average of 0.85 million shares in intraday trading volume over the past 10 days and average of 554.94K shares over the past 3 months.

Analysts have given a consensus recommendation of Buy for I-Mab ADR (IMAB), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give IMAB a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy.

I-Mab ADR (NASDAQ:IMAB) trade information

After registering a -6.11% downside in the last session, I-Mab ADR (IMAB) has traded red over the past five days. The 5-day price performance for the stock is 6.44%, and 14.97% over 30 days. With these gigs, the year-to-date price performance is 32.72%. Short interest in I-Mab ADR (NASDAQ:IMAB) saw shorts transact 0.38 million shares and set a 0.46 days time to cover.

IMAB Dividends

I-Mab ADR has its next earnings report out on 2025-May-15. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

I-Mab ADR (NASDAQ:IMAB)’s Major holders

I-Mab ADR insiders hold 11.18% of total outstanding shares, with institutional holders owning 29.54% of the shares at 33.26% float percentage. In total, 29.54% institutions holds shares in the company, led by HHLR ADVISORS, LTD. As of 2024-06-30, the company held over 6.91 million shares (or 7.7935% of shares), all amounting to roughly $11.54 million.

The next major institution holding the largest number of shares is CALIGAN PARTNERS LP with 3.37 million shares, or about 3.8067% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $5.64 million.

We also have abrdn Healthcare Investors and abrdn Healthcare Opportunities Fund as the top two Mutual Funds with the largest holdings of the I-Mab ADR (IMAB) shares. Going by data provided on Mar 31, 2025, abrdn Healthcare Investors holds roughly 53.88 shares. This is just over 0.07% of the total shares, with a market valuation of $0.12 million. Data from the same date shows that the other fund manager holds a little less at 43.74, or 0.05% of the shares, all valued at about 94036.0.